Summit Trail Advisors’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Other funds holding MEDP
VPM
VCM
WA
Summit Trail Advisors's MEDP Position: Q1 2026 in Review
Summit Trail Advisors increased its Medpace (MEDP) stake by 60% in Q1 2026, buying an estimated $508K and bringing the position to 2,649 shares worth $1.27M. The position accounts for 0.02% of the portfolio, ranked #817.
Summit Trail Advisors first reported a position in MEDP in Q3 2025 and has held it in 3 quarters since. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.
- Summit Trail Advisors held 2,649 shares of Medpace worth $1.27M as of Q1 2026.
- Summit Trail Advisors bought 992 Medpace shares in Q1 2026, an estimated $508K.
- Medpace made up 0.02% of Summit Trail Advisors's portfolio in Q1 2026, its #817 holding.
- Summit Trail Advisors first reported a position in Medpace in Q3 2025 and has held it in 3 quarters since.
- 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.
Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.